BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16443748)

  • 1. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum.
    Campana V; Sarnataro D; Fasano C; Casanova P; Paladino S; Zurzolo C
    J Cell Sci; 2006 Feb; 119(Pt 3):433-42. PubMed ID: 16443748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.
    Sarnataro D; Campana V; Paladino S; Stornaiuolo M; Nitsch L; Zurzolo C
    Mol Biol Cell; 2004 Sep; 15(9):4031-42. PubMed ID: 15229281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial CJD associated PrP mutants within transmembrane region induced Ctm-PrP retention in ER and triggered apoptosis by ER stress in SH-SY5Y cells.
    Wang X; Shi Q; Xu K; Gao C; Chen C; Li XL; Wang GR; Tian C; Han J; Dong XP
    PLoS One; 2011 Jan; 6(1):e14602. PubMed ID: 21298055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
    Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
    J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts.
    Sarnataro D; Paladino S; Campana V; Grassi J; Nitsch L; Zurzolo C
    Traffic; 2002 Nov; 3(11):810-21. PubMed ID: 12383347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective processing and metabolism of disease-causing mutant prion proteins.
    Ashok A; Hegde RS
    PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.
    Wadia JS; Schaller M; Williamson RA; Dowdy SF
    PLoS One; 2008; 3(10):e3314. PubMed ID: 19390657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
    Zou WQ; Cashman NR
    J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proper axonal distribution of PrP(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons.
    Galvan C; Camoletto PG; Dotti CG; Aguzzi A; Ledesma MD
    Mol Cell Neurosci; 2005 Nov; 30(3):304-15. PubMed ID: 16139509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
    Gauczynski S; Krasemann S; Bodemer W; Weiss S
    J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
    J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
    Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
    J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.